There’s a persistent male gender predominance in urology, particularly with respect to feminine illustration in management. We evaluate the present standing of ladies in urology management, talk about challenges ladies face in management positions, current the case for adopting inclusive practices that improve variety and gender fairness in urology management, and evaluate the potential advantages of such an growth.
We talk about sensible methods to develop the position of ladies in urologic management, together with growing mentorship, modifying tutorial promotion standards, and addressing implicit bias, whereas presenting a roadmap in direction of attaining fairness and variety on the highest ranks of urologic management.
Urology throughout a Disaster: A Administration Algorithm
COVID-19 pandemic has affected greater than 1,000,000 individuals worldwide inflicting a public well being disaster. Below these distinctive circumstances, urologists proceed to supply important healthcare providers and assist healthcare programs, by collaborating within the therapy of COVID-19(+) sufferers and sparing very important gear and hospital beds. Nevertheless, delivering medical care in the course of the pandemic requires strategic planning for all surgical and outpatient actions.
Proposed measures embrace rescheduling elective non-oncological surgical procedures and utilizing a prioritization protocol for oncological surgical procedures in line with hospital capability. Following that, outpatient clinics could possibly be partly changed by telemedicine. Moreover, urologists ought to be skilled in screening and treating sufferers with COVID-19 throughout their each day routine.
As a way to effectively present their providers, a administration protocol for suspected or identified COVID-19 urological sufferers ought to be carried out. Moreover, preventive measures for the nosocomial dispersion of the virus and coaching on self-protective gear is necessary for all physicians. Lastly, organizational planning for the perfect utilization of the workers is of utmost significance.
Implementation and adaptation of the protocols in line with native necessities and pointers will ameliorate the standard of providers and inhabitants’s well being standing. Lastly, enhancement of present practices will put together well being programs for future disaster.
The influence of COVID-19 in medical observe. A evaluate centered on Urology
COVID-19 pandemic is a quickly spreading virus that’s altering the World and the best way docs are training medication. The massive variety of sufferers trying to find medical care and needing intensive care beds led the well being care system to a burnout standing particularly in locations the place the care system was already overloaded.
On this setting, and likewise because of the absence of a particular therapy for the illness, well being authorities needed to go for recommending or imposing social distancing to alleviate the well being system and scale back deaths. All different medical specialties non-directly associated to the therapy of COVID-19 needed to interrupt or strongly scale back their actions so as to give room to significantly in poor health sufferers, since nobody is aware of to this point the true extent of the virus injury on human physique and the results of doing non deferrable procedures on this pandemic period.
Regardless of not been a urological illness, the urologist must be up to date on methods to cope with these sufferers and methods to maintain himself and of the medical staff he works with. The intention of this text is to evaluate briefly some sensible facets of COVID-19 and its implications within the urological observe in our nation.
Data hole throughout continents: the andrology and male infertility publicity amongst urology residents in the US and Europe
It’s properly established that resident’s publicity and coaching are of major significance and positively correlated with affected person and well being high quality outcomes. We aimed to check and distinction urology residents’ self-reported views and attitudes towards publicity and training of andrology and male infertility throughout residency in each the US and Europe. We carried out a cross-sectional design research utilizing a survey that was distributed to a consultant pattern of American and European urology residents.
The survey included questions concerning demographics, and the residents’ notion and outline of their coaching on this particular subspecialty. Response information have been analyzed utilizing Chi-square checks. Sixty-five % of European and thirty-five % American urology residents reported feeling uncomfortable in a brand new session evaluating an infertile affected person and deciphering semen analyses.
Surprisingly, greater than half of responders replied that they might not go to their very own coaching establishments searching for for male fertility care (78% US and 58% Europeans). Within the comparative evaluation, though no variations have been noticed within the very low quantity (18%) of hospitals that provide formal microsurgical coaching for urology residents between the US and Europe, extra US establishments have been reported to have an working microscope for urology (68% vs. 41%), and extra US residents replied reported collaborating in at the least one urologic surgical procedure utilizing the microscope (65% vs. 34%).
In conclusion, each American and European residents shared the identical frustration concerning their training and publicity to andrology and male infertility throughout residency coaching. Collaborative efforts between stakeholders are wanted to determine a transparent and centered curriculum and coaching targets to remove this instructional hole.
Administration of urology throughout COVID-19 pandemic: A perspective from Sichuan Province, China
Since first reported in Dec.2019 in Wu Han, China, Novel Coronavirus has captured most cities in China. On Feb.1.2020, Nationwide Well being Fee of the Folks’s Republic of China (NHCC) formally termed the novel coronavirus as COVID-19, which is in accordance with World Well being Group (WHO). Till 14:35, Feb, 21, the variety of recognized instances was 76,178 and 2247 died, amongst which 75,568 and 2239 have been reported in China respectively with an estimated mortality of two.9%.
PE anti-human CD163 |
E16FHP163-025 |
EnoGene |
25 tests |
EUR 433.33 |
Description: Available in various conjugation types. |
PE anti-human CD163 |
E16FHP163-100 |
EnoGene |
100 tests |
EUR 953.33 |
Description: Available in various conjugation types. |
APC anti-human CD163 |
E16FHA163-025 |
EnoGene |
25 tests |
EUR 520 |
Description: Available in various conjugation types. |
APC anti-human CD163 |
E16FHA163-100 |
EnoGene |
100 tests |
EUR 1191.67 |
Description: Available in various conjugation types. |
FITC anti-human CD163 |
E16FHF163-025 |
EnoGene |
25 tests |
EUR 520 |
Description: Available in various conjugation types. |
FITC anti-human CD163 |
E16FHF163-100 |
EnoGene |
100 tests |
EUR 1191.67 |
Description: Available in various conjugation types. |
Biotin anti-human CD163 |
E16FHB163-025U |
EnoGene |
25 μg |
EUR 346.67 |
Description: Available in various conjugation types. |
Biotin anti-human CD163 |
E16FHB163-100U |
EnoGene |
100 μg |
EUR 780 |
Description: Available in various conjugation types. |
Purified anti-human CD163 |
E16FHU163-100U |
EnoGene |
100 μg |
EUR 433.33 |
Description: Available in various conjugation types. |
CD163 (GFP-tagged) - Human CD163 molecule (CD163), transcript variant 1 |
RG208557 |
Origene Technologies GmbH |
10 µg |
Ask for price |
CD163 (GFP-tagged) - Human CD163 molecule (CD163), transcript variant 2 |
RG212754 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Rabbit Anti Human CD163 Monoclonal Clone ABCC-3 |
IRBAHUCD163ABCC3C100UL |
Innovative research |
each |
EUR 496 |
|
Description: Rabbit Anti Human CD163 Monoclonal Clone ABCC-3 |
PE-Cy7 anti-human CD163 |
E16FHN163-025 |
EnoGene |
25 tests |
EUR 650 |
Description: Available in various conjugation types. |
PE-Cy7 anti-human CD163 |
E16FHN163-100 |
EnoGene |
100 tests |
EUR 1408.33 |
Description: Available in various conjugation types. |
APC-Cy7 anti-human CD163 |
E16FHO163-025 |
EnoGene |
25 tests |
EUR 650 |
Description: Available in various conjugation types. |
APC-Cy7 anti-human CD163 |
E16FHO163-100 |
EnoGene |
100 tests |
EUR 1408.33 |
Description: Available in various conjugation types. |
PerCP-Cy5.5 anti-human CD163 |
E16FHS163-025 |
EnoGene |
25 tests |
EUR 541.67 |
Description: Available in various conjugation types. |
PerCP-Cy5.5 anti-human CD163 |
E16FHS163-100 |
EnoGene |
100 tests |
EUR 1278.33 |
Description: Available in various conjugation types. |
Recombinant Human CD163/CD163 Protein, His Tag |
E40KMH346 |
EnoGene |
20ug |
EUR 495 |
CD163 (Myc-DDK-tagged)-Human CD163 molecule (CD163), transcript variant 2 |
RC212754 |
Origene Technologies GmbH |
10 µg |
Ask for price |
CD163 (Myc-DDK-tagged)-Human CD163 molecule (CD163), transcript variant 1 |
RC208557 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Human CD163 Protein |
E40KMPH6242 |
EnoGene |
20ug |
EUR 495 |
anti- CD163/M130 Antibody |
FNab09771 |
FN Test |
100µg |
EUR 658.5 |
|
Description: Antibody raised against CD163/M130 |
Anti-Hu CD163 PE |
1P-645-T025 |
ExBio |
25 tests |
EUR 168 |
Anti-Hu CD163 PE |
1P-645-T100 |
ExBio |
100 tests |
EUR 288 |
Anti-Hu CD163 APC |
1A-645-T025 |
ExBio |
25 tests |
EUR 168 |
Anti-Hu CD163 APC |
1A-645-T100 |
ExBio |
100 tests |
EUR 288 |
Anti-Hu CD163 Purified |
11-645-C025 |
ExBio |
0.025 mg |
EUR 118.8 |
Anti-Hu CD163 Purified |
11-645-C100 |
ExBio |
0.1 mg |
EUR 189.6 |
Human CD163, Fc Tag |
E24PHA282 |
EnoGene |
50 μg |
EUR 250 |
Human CD163, His Tag |
E24PHA281 |
EnoGene |
50 μg |
EUR 250 |
Human CD163 ELISA Kit |
LF-EK50890 |
Abfrontier |
1×96T |
EUR 777.6 |
Human CD163 shRNA Plasmid |
20-abx956176 |
Abbexa |
|
|
|
PE Anti-human CD163 Antibody *GHI/61* |
116301K0 |
AAT Bioquest |
25 tests |
EUR 383 |
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
PE Anti-human CD163 Antibody *GHI/61* |
116301K1 |
AAT Bioquest |
100 tests |
EUR 995 |
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
PE Anti-human CD163 Antibody *GHI/61* |
116301K2 |
AAT Bioquest |
500 tests |
EUR 2984 |
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
PE Anti-human CD163 Antibody *GHI/61* |
116301K0-25tests |
AAT Bioquest |
25 tests |
EUR 383 |
Description: GHI/61 is an anti-human monoclonal antibody that forms an immune complex with the CD163 antigen. |
PE Anti-human CD163 Antibody *GHI/61* |
116301K1-100tests |
AAT Bioquest |
100 tests |
EUR 995 |
Description: GHI/61 is an anti-human monoclonal antibody that forms an immune complex with the CD163 antigen. |
PE Anti-human CD163 Antibody *GHI/61* |
116301K2-500tests |
AAT Bioquest |
500 tests |
EUR 2984 |
Description: GHI/61 is an anti-human monoclonal antibody that forms an immune complex with the CD163 antigen. |
Anti-Hu CD163 PE-Cy7 |
T7-645-T025 |
ExBio |
25 tests |
EUR 184.8 |
Anti-Hu CD163 PE-Cy7 |
T7-645-T100 |
ExBio |
100 tests |
EUR 321.6 |
APC Anti-human CD163 Antibody *GHI/61* |
116301B0 |
AAT Bioquest |
25 tests |
EUR 383 |
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
APC Anti-human CD163 Antibody *GHI/61* |
116301B1 |
AAT Bioquest |
100 tests |
EUR 995 |
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
APC Anti-human CD163 Antibody *GHI/61* |
116301B2 |
AAT Bioquest |
500 tests |
EUR 2984 |
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
APC Anti-human CD163 Antibody *GHI/61* |
116301B0-25tests |
AAT Bioquest |
25 tests |
EUR 383 |
Description: GHI/61 is an anti-human monoclonal antibody that forms an immune complex with the CD163 antigen. |
APC Anti-human CD163 Antibody *GHI/61* |
116301B1-100tests |
AAT Bioquest |
100 tests |
EUR 995 |
Description: GHI/61 is an anti-human monoclonal antibody that forms an immune complex with the CD163 antigen. |
APC Anti-human CD163 Antibody *GHI/61* |
116301B2-500tests |
AAT Bioquest |
500 tests |
EUR 2984 |
Description: GHI/61 is an anti-human monoclonal antibody that forms an immune complex with the CD163 antigen. |
Alexa Fluor® 647 anti-human CD163 |
E16FHK163-025 |
EnoGene |
25 tests |
EUR 433.33 |
Description: Available in various conjugation types. |
Alexa Fluor® 647 anti-human CD163 |
E16FHK163-100 |
EnoGene |
100 tests |
EUR 975 |
Description: Available in various conjugation types. |
FITC Anti-human CD163 Antibody *GHI/61* |
116301G0 |
AAT Bioquest |
100 tests |
EUR 547 |
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
FITC Anti-human CD163 Antibody *GHI/61* |
116301G1 |
AAT Bioquest |
500 tests |
EUR 2051 |
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
FITC Anti-human CD163 Antibody *GHI/61* |
116301G0-100tests |
AAT Bioquest |
100 tests |
EUR 547 |
Description: GHI/61 is an anti-human monoclonal antibody that forms an immune complex with the CD163 antigen. |
FITC Anti-human CD163 Antibody *GHI/61* |
116301G1-500tests |
AAT Bioquest |
500 tests |
EUR 2051 |
Description: GHI/61 is an anti-human monoclonal antibody that forms an immune complex with the CD163 antigen. |
Recombinant Human CD163 Protein |
RP02295 |
Abclonal |
500μg |
EUR 1625 |
|
TRITC Anti-human CD163 Antibody *GHI/61* |
116301H0 |
AAT Bioquest |
100 tests |
EUR 547 |
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
TRITC Anti-human CD163 Antibody *GHI/61* |
116301H1 |
AAT Bioquest |
500 tests |
EUR 2051 |
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
PerCP Anti-human CD163 Antibody *GHI/61* |
116301S0 |
AAT Bioquest |
25 tests |
EUR 383 |
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
PerCP Anti-human CD163 Antibody *GHI/61* |
116301S1 |
AAT Bioquest |
100 tests |
EUR 995 |
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
PerCP Anti-human CD163 Antibody *GHI/61* |
116301S2 |
AAT Bioquest |
500 tests |
EUR 2984 |
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
TRITC Anti-human CD163 Antibody *GHI/61* |
116301H0-100tests |
AAT Bioquest |
100 tests |
EUR 547 |
Description: GHI/61 is an anti-human monoclonal antibody that forms an immune complex with the CD163 antigen. |
TRITC Anti-human CD163 Antibody *GHI/61* |
116301H1-500tests |
AAT Bioquest |
500 tests |
EUR 2051 |
Description: GHI/61 is an anti-human monoclonal antibody that forms an immune complex with the CD163 antigen. |
PerCP Anti-human CD163 Antibody *GHI/61* |
116301S0-25tests |
AAT Bioquest |
25 tests |
EUR 383 |
Description: GHI/61 is an anti-human monoclonal antibody that forms an immune complex with the CD163 antigen. |
PerCP Anti-human CD163 Antibody *GHI/61* |
116301S1-100tests |
AAT Bioquest |
100 tests |
EUR 995 |
Description: GHI/61 is an anti-human monoclonal antibody that forms an immune complex with the CD163 antigen. |
PerCP Anti-human CD163 Antibody *GHI/61* |
116301S2-500tests |
AAT Bioquest |
500 tests |
EUR 2984 |
Description: GHI/61 is an anti-human monoclonal antibody that forms an immune complex with the CD163 antigen. |
Anti-Hu CD163 PerCP-Cy5.5 |
T9-645-T025 |
ExBio |
25 tests |
EUR 235.2 |
Anti-Hu CD163 PerCP-Cy5.5 |
T9-645-T100 |
ExBio |
100 tests |
EUR 422.4 |
PacBlue Anti-human CD163 Antibody *GHI/61* |
116301I0 |
AAT Bioquest |
100 tests |
EUR 547 |
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
PacBlue Anti-human CD163 Antibody *GHI/61* |
116301I1 |
AAT Bioquest |
500 tests |
EUR 2051 |
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
PacBlue Anti-human CD163 Antibody *GHI/61* |
116301I0-100tests |
AAT Bioquest |
100 tests |
EUR 547 |
Description: GHI/61 is an anti-human monoclonal antibody that forms an immune complex with the CD163 antigen. |
PacBlue Anti-human CD163 Antibody *GHI/61* |
116301I1-500tests |
AAT Bioquest |
500 tests |
EUR 2051 |
Description: GHI/61 is an anti-human monoclonal antibody that forms an immune complex with the CD163 antigen. |
Purified Anti-human CD163 Antibody *GHI/61* |
11630000 |
AAT Bioquest |
100 ug |
EUR 365 |
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
Purified Anti-human CD163 Antibody *GHI/61* |
11630000-100ug |
AAT Bioquest |
100 ug |
EUR 365 |
Description: GHI/61 is an anti-human monoclonal antibody that forms an immune complex with the CD163 antigen. |
PacOrange Anti-human CD163 Antibody *GHI/61* |
116301J0 |
AAT Bioquest |
100 tests |
EUR 547 |
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
PacOrange Anti-human CD163 Antibody *GHI/61* |
116301J1 |
AAT Bioquest |
500 tests |
EUR 2051 |
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
PacOrange Anti-human CD163 Antibody *GHI/61* |
116301J0-100tests |
AAT Bioquest |
100 tests |
EUR 547 |
Description: GHI/61 is an anti-human monoclonal antibody that forms an immune complex with the CD163 antigen. |
PacOrange Anti-human CD163 Antibody *GHI/61* |
116301J1-500tests |
AAT Bioquest |
500 tests |
EUR 2051 |
Description: GHI/61 is an anti-human monoclonal antibody that forms an immune complex with the CD163 antigen. |
Human CellExp? CD163, Human recombinant |
9226-10 |
Biovision |
each |
EUR 366 |
Human CellExp? CD163, Human recombinant |
9226-50 |
Biovision |
each |
EUR 927.6 |
Canine CD163 antigen(CD163 LISA kit |
GA-E0062CN-48T |
GenAsia Biotech |
48T |
EUR 482.4 |
Canine CD163 antigen(CD163 LISA kit |
GA-E0062CN-96T |
GenAsia Biotech |
96T |
EUR 820.8 |
ELISA kit for Human CD163 |
EK5296 |
SAB |
96 tests |
EUR 663.6 |
Description: Enzyme-linked immunosorbent assay kit for quantification of Human CD163 in samples from serum, plasma, tissue homogenates and other biological fluids. |
Porcine CD163 antigen,CD163 LISA kit |
GA-E0045PC-48T |
GenAsia Biotech |
48T |
EUR 436.8 |
Porcine CD163 antigen,CD163 LISA kit |
GA-E0045PC-96T |
GenAsia Biotech |
96T |
EUR 708 |
Porcine CD163 antigen, CD163 LISA kit |
KLP0040 |
Krishgen |
1 x 96 wells |
EUR 341 |
Rat CD163 antigen, CD163 GENLISA ELISA |
KLR2081 |
Krishgen |
1 x 96 wells |
EUR 341 |
Human CD163 Protein, His Tag |
CD3-H52E8 |
ACROBIOSYSTEMS |
1mg |
EUR 374.5 |
|
Description: Human CD163, His Tag (CD3-H52E8) is expressed from human 293 cells (HEK293). It contains AA Ser 42 - Ser 1045 (Accession # Q86VB7). |
Cd163 (untagged) - Mouse CD163 antigen (Cd163), transcript variant 2, (10ug) |
MC223654 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Cd163 (untagged) - Mouse CD163 antigen (Cd163), transcript variant 1, (10ug) |
MC223773 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Human CD163 PicoKine ELISA Kit |
EK0715 |
BosterBio |
96 wells |
EUR 510 |
Description: For quantitative detection of human CD163 in cell culture supernates, serum and plasma(heparin). |
Human CD163 knockout cell line |
ABC-KH2671 |
AcceGen |
1 vial |
Ask for price |
Description: Human CD163 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
PE/Cy5 Anti-human CD163 Antibody *GHI/61* |
116301L0 |
AAT Bioquest |
25 tests |
EUR 429 |
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
PE/Cy5 Anti-human CD163 Antibody *GHI/61* |
116301L1 |
AAT Bioquest |
100 tests |
EUR 1117 |
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
PE/Cy5 Anti-human CD163 Antibody *GHI/61* |
116301L2 |
AAT Bioquest |
500 tests |
EUR 3351 |
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
PE/Cy7 Anti-human CD163 Antibody *GHI/61* |
116301M0 |
AAT Bioquest |
25 tests |
EUR 429 |
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
PE/Cy7 Anti-human CD163 Antibody *GHI/61* |
116301M1 |
AAT Bioquest |
100 tests |
EUR 1117 |
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
PE/Cy7 Anti-human CD163 Antibody *GHI/61* |
116301M2 |
AAT Bioquest |
500 tests |
EUR 3351 |
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
PE/Cy5 Anti-human CD163 Antibody *GHI/61* |
116301L0-25tests |
AAT Bioquest |
25 tests |
EUR 429 |
Description: GHI/61 is an anti-human monoclonal antibody that forms an immune complex with the CD163 antigen. |
PE/Cy5 Anti-human CD163 Antibody *GHI/61* |
116301L1-100tests |
AAT Bioquest |
100 tests |
EUR 1117 |
Description: GHI/61 is an anti-human monoclonal antibody that forms an immune complex with the CD163 antigen. |
PE/Cy5 Anti-human CD163 Antibody *GHI/61* |
116301L2-500tests |
AAT Bioquest |
500 tests |
EUR 3351 |
Description: GHI/61 is an anti-human monoclonal antibody that forms an immune complex with the CD163 antigen. |
PE/Cy7 Anti-human CD163 Antibody *GHI/61* |
116301M0-25tests |
AAT Bioquest |
25 tests |
EUR 429 |
Description: GHI/61 is an anti-human monoclonal antibody that forms an immune complex with the CD163 antigen. |
PE/Cy7 Anti-human CD163 Antibody *GHI/61* |
116301M1-100tests |
AAT Bioquest |
100 tests |
EUR 1117 |
Description: GHI/61 is an anti-human monoclonal antibody that forms an immune complex with the CD163 antigen. |
PE/Cy7 Anti-human CD163 Antibody *GHI/61* |
116301M2-500tests |
AAT Bioquest |
500 tests |
EUR 3351 |
Description: GHI/61 is an anti-human monoclonal antibody that forms an immune complex with the CD163 antigen. |
A complete introduction of administration technique involving sufferers and their household, ward, safety and psychological adjustment of medical workers in urology division of West China Hospital throughout COVID-19 epidemic was summarized on this article, by way of which we hope may present reference for different medical facilities.